Back to MPT Database

VivaGel® Vaginal Gel

Development Stage:

Preclinical – Advanced (Pre2)

Hormonal/Non-Hormonal:

Non-Contraceptive

Delivery Route & Method:

Topical - Gel-Vaginal

Mechanism of Action:

Sulfonated dendrimer providing inhibition of attachment; biofilm disruption

Developer:

  • Starpharma Pty Limited

Funding:

  • National Institutes of Health (NIH)
  • Starpharma Pty Limited

Active Ingredient(s):

  • SPL7013 (Astodrimer Sodium)

Product Indication(s):

  • Bacterial Vaginosis (BV)
  • HIV
  • HPV
  • HSV-2

Back to MPT Database